In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 89 (1) , 65-74
- https://doi.org/10.1016/s0304-3959(00)00349-3
Abstract
Capsaicin and analogues are valuable analgesic agents when administered to mammals, including humans. However, their pungency and the effects on the cardiovascular and respiratory systems through their general activation of small calibre (nociceptive) primary afferents severely limit their uKeywords
This publication has 25 references indexed in Scilit:
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- Suppression of bladder hyperreflexia by intravesical resiniferatoxinThe Lancet, 1997
- Differential Activation and Desensitization of Sensory Neurons by ResiniferatoxinJournal of Neuroscience, 1997
- Desensitization of Bladder Sensory Fibers by Intravesical Capsaicin has Long Lasting Clinical and Urodynamic Effects in Patients With Hyperactive or Hypersensitive Bladder DysfunctionJournal of Urology, 1997
- Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchiEuropean Journal of Pharmacology, 1992
- Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin‐induced antinociceptionBritish Journal of Pharmacology, 1991
- Neuropeptides in the Respiratory Tract: Part IAmerican Review of Respiratory Disease, 1991
- Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in cultureNeuroscience, 1991
- A spinal mechanism of action is involved in the antinociception produced by the capsaicin analogue NE 19550 (olvanil)Pain, 1990
- Antinociception produced by capsaicin: spinal or peripheral mechanism?European Journal of Pharmacology, 1990